EUVIMEDEUVIMED entdecken
Open Access

Neutrophil Elastase Inhibition by Sivelestat (ONO-5046) Attenuates AngII-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice

Yoshiko Hada, Haruhito A Uchida iD, Shugo Okamoto, Nozomu Otaka, Katsuyoshi Katayama, Venkateswaran Subramanian, Alan Daugherty, Jun Wada

American Journal of Hypertension · 2024

DOI: 10.1093/ajh/hpad107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, 2024. Verfasst von Yoshiko Hada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Science, …. Hauptthemen laut MEDLINE: Angiotensin II, Aortic Aneurysm, Abdominal, Glycine, Leukocyte Elastase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Abdominal aortic aneurysm (AAA) is an arterial disease characterized by dilatation of the aortic wall. It has been suggested that neutrophil counts and neutrophil elastase activity are associated with AAA. We investigated whether a neutrophil elastase (NE) inhibitor, sivelestat (Siv), had a protective effect against angiotensin II (AngII)-induced AAAs. METHODS Male apolipoprotein E-deficient mice were assigned into three groups: Vehicle + saline, AngII + saline, and AngII + Siv. All mice were administered intraperitoneally with either Siv or vehicle twice daily after AngII infusion. RESULTS In the 4-week AngII infusion study, plasma NE concentration (P = 0.041) and its activity (P = 0.011) were elevated by AngII. These increases were attenuated by Siv (concentration:P = 0.010, activity:P = 0.027). Further, plasma elastase activity was closely correlated with aortic width (R = 0.6976, P < 0.001). In the 1-week AngII infusion study, plasma and tissue elastase activity increased by AngII (plasma:P = 0.034, tissue:P < 0.001), but were reduced by Siv (plasma:P = 0.014, tissue:P = 0.024). AngII increased aortic width (P = 0.011) but was attenuated by co-administration of Siv (P = 0.022). Moreover, Siv decreased the incidence of AAAs (P = 0.009). Elastin fragmentation induced by AngII was reduced by Siv. Many inflammatory cells that were either CD68 or Gr-1 positive were observed in the AngII + saline group, whereas few inflammatory cells were accumulated in the AngII + Siv group. MMP-2 and MMP-9 were enhanced by AngII, but were reduced by Siv. In vitro, MMP-2 activity was induced by human NE (medium:P < 0.001, cells:P = 0.001), which was attenuated by co-incubation of Siv in medium (P < 0.001) and protein of human aortic smooth muscle cells (P = 0.001). CONCLUSIONS Siv attenuated AngII-induced AAA through the inhibition of NE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin IIAortic Aneurysm, AbdominalGlycineLeukocyte ElastaseSulfonamidesAnimalsHumansMiceAorta, AbdominalApolipoproteinsDisease Models, AnimalMatrix Metalloproteinase 2Mice, Inbred C57BLMice, KnockoutApolipoproteins E

Stichwörter der Autor:innen

abdominal aortic aneurysmblood pressureelastasehuman aortic smooth muscle cellshypertensionsivelestat

Substanzen

Angiotensin IIApolipoproteinsGlycineLeukocyte ElastaseMatrix Metalloproteinase 2sivelestatSulfonamidesApoe protein, mouseApolipoproteins E

Autor:innen und Institutionen

  • Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan.
  • Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan.
  • Department of Nephrology and Rheumatology, Kagawa Prefectural Central Hospital, Kagawa, Japan.
  • Division of Cardiovascular Medicine, Department of Medicine, University of Missouri, Columbia, Missouri, USA.
  • Saha Cardiovascular Research Center, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Physiology, University of Kentucky, Lexington, Kentucky, USA.

ORCID-Profile: Haruhito A Uchida

Förderung

  • NHLBI NIH HHS
  • NIH

Zitieren

APA

Hada, Y., Uchida, H. A., Okamoto, S., Otaka, N., Katayama, K., Subramanian, V., Daugherty, A., & Wada, J. (2024). Neutrophil Elastase Inhibition by Sivelestat (ONO-5046) Attenuates AngII-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpad107

Vancouver

Hada Y, Uchida HA, Okamoto S, Otaka N, Katayama K, Subramanian V, et al. Neutrophil Elastase Inhibition by Sivelestat (ONO-5046) Attenuates AngII-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. American Journal of Hypertension. 2024. doi:10.1093/ajh/hpad107

BibTeX
@article{Hada2024,
  author = {Hada, Yoshiko and Uchida, Haruhito A and Okamoto, Shugo and Otaka, Nozomu and Katayama, Katsuyoshi and Subramanian, Venkateswaran and Daugherty, Alan and Wada, Jun},
  title = {Neutrophil Elastase Inhibition by Sivelestat (ONO-5046) Attenuates AngII-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice},
  journal = {American Journal of Hypertension},
  year = {2024},
  doi = {10.1093/ajh/hpad107}
}
Kostenlos starten →